Hardcover: 423 pages ; Dimensions (in inches): 1.02 x 9.66 x 7.12
Publisher: Vch Verlagsgesellschaft Mbh; (May 2003)
 
**** 해외주문도서입니다. 10일정도 소요예정입니다.******

Short description
This book is the very first one focusing on the proteomic and genomic analysis of cardiovascular disease, the number one killer in the industrial world. Organized in two parts the book describes the potentials but also the limitations of these technologies. The various strategies and technical aspects that will assist the growing number of researchers in the cardiovascular area attempting to utilize these approaches are highlighted.

From the contents
GENOMICS
Large scale expression profiling in cardiovascular disease using microarrays: prospects and pitfalls
Global Genomic Analyses of Cardiovascular Disease: A Potential Map or Blind Alley?
Heart Failure: A Genomics Perspective
Experimental application of the genomic microarray analysis of both human and animal models of heart failure
Gene Profiling in the Heart by Subtractive Hybridization
DNA Mircoarray Gene Profiling: A Tool for the Elucidation of Cardioprotective Genes
Pitfalls Associated With cDNA Microarrays; A Cautionary Tale
Application of Biologic Skepticism to Analysis of Expression Phenotypes
Genes involved in atherosclerosis and plaque formation
PROTEOMICS
Proteomics of the Cardiovascular Disease - A Step Beyond Genomics
Mass spectrometry - A Powerful Analytical Tool
Differential Expression Proteomic Analysis Using Isotope Coded Affinity Tags
Protein chip technology in proteomics analysis
Recent Applications of Functional Proteomics: investigations in smooth muscle cell physiology
Gene Expression Profiling in Pulmonary and Systemic Vascular Cells Exposed to Biomechanical Stimuli
Identification of Targets of Phosphorylation in Heart Mitochondria
Proteomic Characterization of Protein Kinase C Signaling Tasks in the Heart
Identification of Secreted Oxidative Stress-Induced Factors (SOXF) and Associated Proteins: Proteomics in Vascular Biology
Myofilament proteomics: understanding contractile dysfunction in cardiorespiratory disease
FUTURE PERSPECTIVES
Genomics Perspective for Drug Discovery
Proteomics: A Post-Genomic Platform for Drug Discovery and Development